yu du

Dr. yu du


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2024 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
LYLi Ye
Li Ye
SLShangxuan Li
Shangxuan Li
CLChichi Li
Chichi Li
CWCheng Wang
Cheng Wang
XWXi Wei
Xi Wei
YDyu du
yu du
This study aims to verify the effectiveness of a deep neural network (DNN) in automatically identifying pulp calcification on cone beam computed tomography (CBCT) images. This study retrospectively analysed 150 CBCT images. Pulp calcification was identified and manually annotated by three endodontists with 10 years of experience. A DNN model based on the U-Net architecture was constructed to identify pulp calcification, and ten rounds of fourfold cross-validation were conducted. The model performance was evaluated using sensitivity, specificity, accuracy, and the area under the receiver operating characteristic curve (AUC). The model achieved a sensitivity of 75.91 ± 2.84% in automatically identifying pulp calcification, with a specificity of 68.88 ± 2.35%, an accuracy of 72.78 ± 2.13%, and an AUC of 73.68 ± 3.09%. According to the ranking for diagnostic tests, the proposed method achieved a “good” grade for sensitivity, accuracy, and AUC and a “fair” grade for specificity. The results indicate that the proposed method shows promise for identifying pulp calcification on CBCT images. Future research aims to expand the dataset and refine the model, thereby enhancing its clinical applicability. The integration of artificial intelligence into diagnostic and treatment systems is anticipated to increase the efficiency of diagnosing pulp calcification and assist dentists in assessing the difficulty of root canal treatment cases preoperatively. Registration was performed on the Chinese Clinical Trial Registry ( https://www.chictr.org.cn/ ) (Registration number: ChiCTR2300077078, 27/10/2023) and National Medical Research Registry Information System ( https://www.medicalresearch.org.cn/ , 30/10/2023) (Number: MR-44–23-039664).

2 March 2023 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
GLGuixian Li
Guixian Li
ZXZhiqing Xu
Zhiqing Xu
MYMaobin Yang
Maobin Yang
YNYang Ning
Yang Ning
LYLi Ye
Li Ye
YDyu du
yu du

23 August 2025 in Artificial Intelligence in Medicine
Verified
Journal Article
Closed access
TZTao Zhong
Tao Zhong
YNYANG NING
YANG NING
XWXueyang Wu
Xueyang Wu
LYLi Ye
Li Ye
CLChichi Li
Chichi Li
YDyu du
yu du

6 June 2024 in Heliyon
Verified
Journal Article
Open access
CXCheng Xu
Cheng Xu
ZXZhiqing Xu
Zhiqing Xu
GLGuixian Li
Guixian Li
JLJing Li
Jing Li
LYLi Ye
Li Ye
YDyu du
yu du
Dental follicle cells (DFCs) promote bone regeneration in vivo and in vitro. Circular RNAs (circRNAs) play crucial roles in bone development and regeneration. Our previous study demonstrated the upregulation of circFgfr2 expression during the osteogenic differentiation of DFCs. However, the molecular mechanisms and functional roles of circFgfr2 in DFCs osteogenesis remain unclear. In this study, we aimed to investigate the subcellular localization of circFgfr2 in DFCs using fluorescence in situ hybridization. In vitro investigations demonstrated that circFgfr2 overexpression promoted osteogenic differentiation, as evidenced by real-time quantitative polymerase chain reaction. By integrating the outcomes of bioinformatics analyses, dual luciferase reporter experiments, and chromatin isolation by RNA purification, we identified circFgfr2 as a sponge for miR-133a-3p, a key regulator of osteogenic differentiation. Moreover, miR-133a-3p suppressed osteogenic differentiation by targeting DLX3 and RUNX2 in DFCs. We validated that circFgfr2 promoted the osteogenic differentiation of DFCs through the miR-133a-3p/DLX3 axis. To further investigate the therapeutic potential of circFgfr2 in bone regeneration, we conducted in vivo experiments and histological analyses. Overall, these results confirmed the crucial role of circFgfr2 in promoting osteogenesis. In summary, our findings demonstrated that the circFgfr2/miR-133a-3p/DLX3 pathway acts as a cascade, thereby identifying circFgfr2 as a promising molecular target for bone tissue engineering.